Prospects for xenotransplantation

Pediatric Transplantation

Volumn 3, Issue 3, 1999, Pages 193-200

  Platt, Jeffrey L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Complement; Endothelial cell; Xenograft; Xenotransplantation

Indexed keywords

COMPLEMENT;

ARTICLE; DISEASE TRANSMISSION; ENDOTHELIUM CELL; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; MOLECULAR INTERACTION; NONHUMAN; ORGAN DONOR; POSTOPERATIVE COMPLICATION; XENOGRAFT; XENOTRANSPLANTATION; ZOONOSIS;

ACUTE DISEASE; ADULT; AGE FACTORS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CHILD; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INFANT, NEWBORN; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PAPIO; PRIMATES; SWINE; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS; ZOONOSES;

EID: 0032768183     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.1999.00040.x     Document Type: Article

References (57)

1. EVANS RW, ORIANS CE, ASCHER NL. The potential supply of organ donors: an assessment of the efficiency of organ procurement efforts in the United States. J Am Med Assoc 1992: 267: 239-246.
2. STARZL TE, FLING J, TZAKIS A, et al. Baboon-to-human liver transplantation. Lancet 1993: 341: 65-71.
3. LIN SS, PLATT JL. Genetic therapies for xenotransplantation. J Am Coll Surg 1998: 186: 388-396.
4. BUSTOS M, PLATT JL. Immunological issues in xenotransplantation. Mol Diagnosis 1996: 1: 225-233.
5. PLATT JL. New directions for organ transplantation. Nature 1998: 392 (Suppl.): 11-17.
6. COOPER DKC, KEMP E, REEMTSMA K, WHITE DJG. Xenotransplantation: the transplantation of organs and tissues between species. Berlin: Springer-Verlag, 1997.
7. LIN SS, PLATT JL. Immunologic barriers to xenotransplantation. J Heart Lung Transplant 1996: 15: 547-555.
8. PLATT JL. Xenotransplantation: recent progress and current perspectives. Curr Opin Immunol 1996: 8: 721-728.
9. GUNSALUS JR, BRADY DA, COULTER SM, GRAY BM, EDGE A Reduction of serum cholesterol in watanabe rabbits by xenogeneic hepatocellular transplantation. Nature Med 1997: 3: 48-53.
10. DEACON T, SCHUMACHER J, DINSMORE J, et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nature Med 1997: 3: 350-353.
11. SAADI S, PLATT JL. Immunology of Xenotransplantation. Life Sci 1997: 62: 365-387.
12. PLATT JL, FISCHEL RJ, MATAS AJ, REIF SA, BOLMAN RM, BACH FH. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991: 52: 214-220.
13. PLATT JL. Hyperacute Xenograft Rejection. New York: R. G. Landes, 1995.
14. CALNE RY. Organ transplantation between widely disparate species. Transplant Proc 1970: 2: 550-556.
15. PARKER W, Yu PB, HOLZKNECHT ZE, LUNDBERG-SWANSON K, BUCKLEY RH, PLATT JL. Specificity and function of 'natural' antibodies in immunodeficient subjects: Clues to B-cell lineage and development. J Clin Immunology 1997: 17: 311-321.
16. GALILI U, CLARK MR, SHOHET SB, BUEHLER J, MACHER BA. Evolutionary relationship between the natural anti-Gal antibody and the Galα1-3Gal epitope in primates. Proc Natl Acad Sci USA 1987: 84: 1369-1373.
17. GOOD AH, COOPER DKC, MALCOLM AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992: 24: 559-562.
18. DALMASSO AP, VERCELLOTTI GM, FISCHEL RJ, BOLMAN RM, BACH FH, PLATT JL. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992: 140: 1157-1166.
19. PLATT JL, VERCELLOTTI GM, DALMASSO AP, et al. Transplantation of discordant xenografts: A review of progress. Immunol Today 1990: 11: 450-456.
20. FISCHEL RJ, MATAS AJ, PLATT JL, et al. Cardiac xenografting in the pig to rhesus model; Manipulation of anti-endothelial antibody prolongs survival. J Heart Lung Transplant 1992: 11: 965-974.
21. COOPER DKC, HUMAN PA, LEXER G, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1988: 7: 238-246.
22. LEVENTHAL JR, DALMASSO AP, CROMWELL JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993: 55: 857-866.
23. SACHS DH, SABLINSKI T Tolerance across discordant xenogeneic barriers. Xenotransplantation 1995: 2: 234-239.
24. LIN SS, KOOYMAN DL, DANIELS LJ, et al. The role of natural anti-Galα1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transplant Immunol 1997: 5: 212-218.
25. SANDRIN MS, FODOR WL, MOUHTOURIS E, et al. Enzymatic remodelling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Med 1995: 1: 1261-1267.
26. SHARMA A, OKABE JF, BIRCH P, PLATT JL, LOGAN JS. Reduction in the level of gal (α1,3) gal in transgenic mice and pigs by the expression of an α(1,2) fucosyltransferase. Proc Natl Acad Sci USA 1996: 93: 7190-7195.
27. PRUITT SK, KIRK AD, BOLLINGER RR, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994: 57: 363-370.
28. COTTERELL AH, COLLINS BH, PARKER W, HARLAND RC. PLATT JL. The humoral immune response in humans following cross-perfusion of porcine organs. Transplantation 1995: 60: 861-868.
29. HOURCADE D, HOLERS VM, ATKINSON JP. The regulators of complement activation (RCA) gene cluster. Adv Immunol 1989: 45: 381-416.
30. DALMASSO AP, VERCELLOTTI GM, PLATT JL, BACH FH. Inhibition of complement-mediated endothelial cell cytotoxicity by decay accelerating factor: Potential for prevention of xenograft hyperacute rejection. Transplantation 1991: 52: 530-533.
31. WHITE D, WALLWORK J. Xenografting: Probability, possibility, or pipe dream? Lancet 1993: 342: 879-880.
32. MCCURRY KR, KOOYMAN DL, ALVARADO CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med 1995: 1: 423-427.
33. BYRNE GW, MCCURRY KR, MARTIN MJ, MCCLELLAN SM, PLATT JL, LOGAN JS. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 1997: 63: 149-155.
34. COZZI E, YANNOUTSOS N, LANGFORD GA, et al. Effect of transgenic expression of human decay-accelerating factor on the inhibition of hyperacute rejection of pig organs. In: COOPER DKC, KEMP E, PLATT JL, WHITE DJG, eds. Xenotransplantation: The transplantation of organs and tissues between species. Berlin: Springer, 1997. pp. 665-682.
35. LEVENTHAL JR, MATAS AJ, SUN LH, et al. The immunopathology of cardiac xenograft rejection in the guinea pig to rat model. Transplantation 1993: 56: 1-8.
36. NAGAYASU T, PLATT JL. Progress in Xenotransplantation. Graft 1998: 1: 19-24.
37. SAADI S, HOLZKHECHT RA, PATTE CP, STERN DM, PLATT JL. Complement-mediated regulation of tissue factor activity in endothelium. J Exp Medicine 1995: 182: 1807-1814.
38. HOLZKNECHT ZE, PLATT JL. Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive antibodies. J Immunol 1995: 154: 4565-4575.
39. SAADI S, IHRCKE NS, PLATT JL. Pathophysiology of xenograft rejection. In: LIEBERMAN R, MORRIS R, eds. Principles of Immunomodulatory Drug Development in Transplantation and Autoimmunity. New York, NY: Raven Press, 1996. pp. 31-45.
40. PLATT JL, MORA NP. Superacion de las barreras entre especies: immunologia del rechazo en el xenotrasplante. Madrid: Fundacion de ciencias de la Salud: in press.
41. MCCURRY KR, PARKER W, COTTERELL AH, et al. Humoral responses in pig-to-baboon cardiac transplantation: Implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. Human Immunol 1997: 58: 91-105.
42. YANG Y-G, dEGOMA E, OHDAN H, et al. Tolerization of anti-Galα1 3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med 1998: 187: 1335-1342.
43. BRACY JL, SACHS DH, IACOMINI J. Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science 1998: 281: 1845-1847.
44. ROBSON SC, YOUNG VK, COOK NS, et al. Thrombin inhibition in an ex vivo model of porcine heart xenograft hypcracutc rejection. Transplantation 1996: 61: 862-868.
45. BACH FH, FERRAN C, HECHENLEITNER P, et al. Accommodation of vascularized xenografts: Expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment. Nature Med 1997: 3: 196-204.
46. CHOPEK MW, SIMMONS RL, PLATT JL. ABO incompatible renal transplantation: Initial immunopathologic evaluation. Transplant Proc 1987: 19: 4553-4557.
47. ZHAO Y, SWENSON K, SERGIO JJ, ARN JS, SACHS DH, SYKES M. Skin graft tolerance across a discordant xenogeneic barrier. Nature Med 1996: 2: 1211-1216.
48. LI H, RICORDI C, DEMETRIS AJ, et al. Mixed xenogeneic chimerism (mouse+rat*>mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts. Transplantation 1994: 57: 592-598.
49. STARZL TE, DEMETRIS AJ, MURASE N, ILDSTAD S, RICORDI C, TRUCCO M. Cell migration, chimerism, and graft acceptance. Lancet 1992: 339: 1579-1582.
50. INVERARDI L, SAMAJA M, MOTTERLINI R, MANGILI F, BENDER JR, PARDI R Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol 1992: 149: 1416-1423.
51. MALYGUINE AM, SAADI S, HOLZKNECHT RA, et al. Induction of procoagulant function in porcine endothelial cells by human NK cells. J Immunol 1997: 159: 4659-4664.
52. AKHTER SA, SKAER CA, KYPSON AP, et al. Restoration of b-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sei USA 1997: 94: 12100-12105.
53. KYPSON AP, PEPPEL K, AKHTER SA, et al. Ex vivo adenoviral-mediated gene transfer to the adult rat heart. J Thorac Cardiovasc Surg 1998: 115: 623-630.
54. PATIENCE C, TAKEUCHI Y, WEISS RA. Infection of human cells by an endogenous retrovirus of pigs. Nature Med 1997: 3: 282-286.
55. GROTH CG, KORSGREN O, TIBELL A, et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994: 344: 1402-1404.
56. CHARI RS, COLLINS BH, MAGEE JC, et al. Treatment of hepatic failure with ex-vivo pig liver perfusion followed by liver transplantation. N Engl J Med 1994: 331: 234-237.
57. ISACSON O, DEACON TW, PAKZABAN P, GALPERN WR, DINSMORE J, BURNS LH. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificty and distinct growth patterns of glial and axonal fibers. Nature Med 1995: 1: 1189-1194.